The Angiogenic Biomarker Endocan is Upregulated in Proliferative Diabetic Retinopathy and Correlates with Vascular Endothelial Growth Factor
Authors:
- Mohd Imtiaz NawazMohd Imtiaz Nawaz
- Gert De HertoghGHGert De Hertogh
- Abdullah S. Al-KharashiAAAbdullah S. Al-Kharashi
- Kathleen Van Den EyndeKEKathleen Van Den Eynde
- Ghulam MohammadGMGhulam Mohammad
- Karel GeboesKGKarel Geboes
- 15 May 2014
- journal article
- Published by Taylor & Francis in Current Eye Research
- Vol. 40 (3) , 321-331
Abstract
Endocan is a proteoglycan specifically secreted by endothelial cells, is a marker of angiogenesis and endothelial cell activation in response to proangiogenic signals. The aim of this study was to measure the levels of endocan in the vitreous fluid from patients with proliferative diabetic retinopathy (PDR) and to correlate its levels with clinical disease activity and the levels of the angiogenic biomarkers vascular endothelial growth factor (VEGF), soluble vascular endothelial-cadherin (sVE-cadherin) and soluble endoglin (sEng). In addition, we investigated the expression of endocan and correlated it with the level of vascularization in PDR epiretinal membranes. Vitreous samples from 44 PDR and 29 non-diabetic patients were studied by enzyme-linked immunosorbent assay. Epiretinal membranes from 14 patients with PDR were studied by immunohistochemistry. Endocan, VEGF, sVE-cadherin and sEng levels were significantly higher in PDR patients than in non-diabetic patients (p < 0.001; p = 0.002; p < 0.001; p = 0.001, respectively). Endocan levels were significantly higher in patients with active PDR than in patients with inactive PDR and non-diabetic patients (p < 0.001). There were significant positive correlations between endocan levels and the levels of VEGF (r = 0.574, p < 0.001) and sVE-cadherin (r = 0.498, p < 0.001). In epiretinal membranes, vascular endothelial cells and myofibroblasts expressed endocan. There was a significant positive correlation between the number of blood vessels expressing CD34 and the number of blood vessels expressing endocan (r = 0.933, p < 0.001). Our findings suggest that upregulation of endocan expression in PDR could be a reflection of endothelial cell activation associated with angiogenesis.Keywords
This publication has 36 references indexed in Scilit:
- Treatment of proliferative diabetic retinopathy with anti-VEGF agentsActa Ophthalmologica, 2011
- Identification and functional analysis of endothelial tip cell–enriched genesBlood, 2010
- Microarray analysis of retinal endothelial tip cells identifies CXCR4 as a mediator of tip cell morphology and branchingBlood, 2010
- Vascular endocan is preferentially expressed in tumor endotheliumMicrovascular Research, 2006
- Endocan Expression and Relationship with Survival in Human Non–Small Cell Lung CancerClinical Cancer Research, 2006
- Angiogenesis in health and diseaseNature Medicine, 2003
- Identification of endothelial cell genes by combined database mining and microarray analysisPhysiological Genomics, 2003
- Endocan Is a Novel Chondroitin Sulfate/Dermatan Sulfate Proteoglycan That Promotes Hepatocyte Growth Factor/Scatter Factor Mitogenic ActivityJournal of Biological Chemistry, 2001
- New concepts in pathogenesis and treatment of diabetic retinopathyExperimental and Clinical Endocrinology & Diabetes, 2001
- ESM-1 Is a Novel Human Endothelial Cell-specific Molecule Expressed in Lung and Regulated by CytokinesJournal of Biological Chemistry, 1996